BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Atkuri KR, Cowan TM, Kwan T, Ng A, Herzenberg LA, Herzenberg LA, Enns GM. Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia. Proc Natl Acad Sci U S A 2009;106:3941-5. [PMID: 19223582 DOI: 10.1073/pnas.0813409106] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Balasubramaniam S, Lewis B, Mock DM, Said HM, Tarailo-Graovac M, Mattman A, van Karnebeek CD, Thorburn DR, Rodenburg RJ, Christodoulou J. Leigh-Like Syndrome Due to Homoplasmic m.8993T>G Variant with Hypocitrullinemia and Unusual Biochemical Features Suggestive of Multiple Carboxylase Deficiency (MCD). JIMD Rep 2017;33:99-107. [PMID: 27450367 DOI: 10.1007/8904_2016_559] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
2 Rüfenacht V, Häberle J. Mini-Review: Challenges in Newborn Screening for Urea Cycle Disorders. IJNS 2015;1:27-35. [DOI: 10.3390/ijns1010027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
3 Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry. 2012;17:290-314. [PMID: 21263444 DOI: 10.1038/mp.2010.136] [Cited by in Crossref: 413] [Cited by in F6Publishing: 392] [Article Influence: 37.5] [Reference Citation Analysis]
4 da Rosa MS, Seminotti B, Ribeiro CA, Parmeggiani B, Grings M, Wajner M, Leipnitz G. 3-Hydroxy-3-methylglutaric and 3-methylglutaric acids impair redox status and energy production and transfer in rat heart: relevance for the pathophysiology of cardiac dysfunction in 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. Free Radic Res 2016;50:997-1010. [PMID: 27430492 DOI: 10.1080/10715762.2016.1214952] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
5 Richard E, Jorge-Finnigan A, Garcia-Villoria J, Merinero B, Desviat LR, Gort L, Briones P, Leal F, Pérez-Cerdá C, Ribes A, Ugarte M, Pérez B; MMACHC Working Group. Genetic and cellular studies of oxidative stress in methylmalonic aciduria (MMA) cobalamin deficiency type C (cblC) with homocystinuria (MMACHC). Hum Mutat 2009;30:1558-66. [PMID: 19760748 DOI: 10.1002/humu.21107] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 5.2] [Reference Citation Analysis]
6 Maresca A, Del Dotto V, Capristo M, Scimonelli E, Tagliavini F, Morandi L, Tropeano CV, Caporali L, Mohamed S, Roberti M, Scandiffio L, Zaffagnini M, Rossi J, Cappelletti M, Musiani F, Contin M, Riva R, Liguori R, Pizza F, La Morgia C, Antelmi E, Loguercio Polosa P, Mignot E, Zanna C, Plazzi G, Carelli V. DNMT1 mutations leading to neurodegeneration paradoxically reflect on mitochondrial metabolism. Hum Mol Genet 2020;29:1864-81. [PMID: 31984424 DOI: 10.1093/hmg/ddaa014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Hurko O. Drug development for rare mitochondrial disorders. Neurotherapeutics 2013;10:286-306. [PMID: 23430661 DOI: 10.1007/s13311-013-0179-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
8 Stepien KM, Heaton R, Rankin S, Murphy A, Bentley J, Sexton D, Hargreaves IP. Evidence of Oxidative Stress and Secondary Mitochondrial Dysfunction in Metabolic and Non-Metabolic Disorders. J Clin Med 2017;6:E71. [PMID: 28753922 DOI: 10.3390/jcm6070071] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 9.6] [Reference Citation Analysis]
9 Teskey G, Abrahem R, Cao R, Gyurjian K, Islamoglu H, Lucero M, Martinez A, Paredes E, Salaiz O, Robinson B, Venketaraman V. Glutathione as a Marker for Human Disease. Adv Clin Chem 2018;87:141-59. [PMID: 30342710 DOI: 10.1016/bs.acc.2018.07.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 10.8] [Reference Citation Analysis]
10 Fu R, Yanjanin NM, Bianconi S, Pavan WJ, Porter FD. Oxidative stress in Niemann-Pick disease, type C. Mol Genet Metab 2010;101:214-8. [PMID: 20667755 DOI: 10.1016/j.ymgme.2010.06.018] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 6.5] [Reference Citation Analysis]
11 Wang S, Liu Y, Liu J, Tian W, Zhang X, Cai H, Fang S, Yu B. Mitochondria-derived methylmalonic acid, a surrogate biomarker of mitochondrial dysfunction and oxidative stress, predicts all-cause and cardiovascular mortality in the general population. Redox Biol 2020;37:101741. [PMID: 33035815 DOI: 10.1016/j.redox.2020.101741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wongkittichote P, Cunningham G, Summar ML, Pumbo E, Forny P, Baumgartner MR, Chapman KA. Tricarboxylic acid cycle enzyme activities in a mouse model of methylmalonic aciduria. Mol Genet Metab 2019;128:444-51. [PMID: 31648943 DOI: 10.1016/j.ymgme.2019.10.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Mori M, Mytinger JR, Martin LC, Bartholomew D, Hickey S. m.8993T>G-Associated Leigh Syndrome with Hypocitrullinemia on Newborn Screening. JIMD Rep 2014;17:47-51. [PMID: 25240982 DOI: 10.1007/8904_2014_332] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
14 Ray SK, Mukherjee S. Molecular and biochemical investigations of inborn errors of metabolism-altered redox homeostasis in branched-chain amino acid disorders, organic acidurias, and homocystinuria. Free Radic Res 2021;:1-14. [PMID: 33504220 DOI: 10.1080/10715762.2021.1877286] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Enns GM, Cowan TM. Glutathione as a Redox Biomarker in Mitochondrial Disease-Implications for Therapy. J Clin Med 2017;6:E50. [PMID: 28467362 DOI: 10.3390/jcm6050050] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
16 Yin C, Xiong K, Huo F, Salamanca JC, Strongin RM. Fluoreszenzsonden mit mehreren Bindungsstellen unterscheiden zwischen Cys, Hcy und GSH. Angew Chem 2017;129:13368-79. [DOI: 10.1002/ange.201704084] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
17 Manoli I, Venditti CP. Disorders of branched chain amino acid metabolism. Transl Sci Rare Dis 2016;1:91-110. [PMID: 29152456 DOI: 10.3233/TRD-160009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
18 Staretz‐chacham O, Wormser O, Manor E, Birk OS, Ferreira CR. TMEM70 deficiency: Novel mutation and hypercitrullinemia during metabolic decompensation. Am J Med Genet 2019. [DOI: 10.1002/ajmg.a.61138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Gamage AM, Lee KO, Gan YH. Effect of oral N-acetyl cysteine supplementation in type 2 diabetic patients on intracellular glutathione content and innate immune responses to Burkholderia pseudomallei. Microbes Infect 2014;16:661-71. [PMID: 25088507 DOI: 10.1016/j.micinf.2014.07.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
20 da Rosa MS, Seminotti B, Amaral AU, Fernandes CG, Gasparotto J, Moreira JCF, Gelain DP, Wajner M, Leipnitz G. Redox homeostasis is compromised in vivo by the metabolites accumulating in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency in rat cerebral cortex and liver. Free Radical Research 2013;47:1066-75. [DOI: 10.3109/10715762.2013.853876] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
21 Gopan A, Sarma MS. Mitochondrial hepatopathy: Respiratory chain disorders- ‘breathing in and out of the liver’. World J Hepatol 2021; 13(11): 1707-1726 [PMID: 34904040 DOI: 10.4254/wjh.v13.i11.1707] [Reference Citation Analysis]
22 Karve TM, Cheema AK. Small changes huge impact: the role of protein posttranslational modifications in cellular homeostasis and disease. J Amino Acids 2011;2011:207691. [PMID: 22312457 DOI: 10.4061/2011/207691] [Cited by in Crossref: 170] [Cited by in F6Publishing: 158] [Article Influence: 15.5] [Reference Citation Analysis]
23 Balachandar V, Rajagopalan K, Jayaramayya K, Jeevanandam M, Iyer M. Mitochondrial dysfunction: A hidden trigger of autism? Genes Dis 2021;8:629-39. [PMID: 34291134 DOI: 10.1016/j.gendis.2020.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Peng M, Ostrovsky J, Kwon YJ, Polyak E, Licata J, Tsukikawa M, Marty E, Thomas J, Felix CA, Xiao R, Zhang Z, Gasser DL, Argon Y, Falk MJ. Inhibiting cytosolic translation and autophagy improves health in mitochondrial disease. Hum Mol Genet 2015;24:4829-47. [PMID: 26041819 DOI: 10.1093/hmg/ddv207] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
25 Khodamoradi K, Amini-Khoei H, Khosravizadeh Z, Hosseini SR, Dehpour AR, Hassanzadeh G. Oxidative stress, inflammatory reactions and apoptosis mediated the negative effect of chronic stress induced by maternal separation on the reproductive system in male mice. Reprod Biol 2019;19:340-8. [PMID: 31711846 DOI: 10.1016/j.repbio.2019.10.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
26 Enns GM, Moore T, Le A, Atkuri K, Shah MK, Cusmano-Ozog K, Niemi AK, Cowan TM. Degree of glutathione deficiency and redox imbalance depend on subtype of mitochondrial disease and clinical status. PLoS One 2014;9:e100001. [PMID: 24941115 DOI: 10.1371/journal.pone.0100001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
27 Larijani B, Foroughi Heravani N, Alavi-Moghadam S, Goodarzi P, Rezaei-Tavirani M, Payab M, Gholami M, Razi F, Arjmand B. Cell Therapy Targets for Autism Spectrum Disorders: Hopes, Challenges and Future Directions. Adv Exp Med Biol 2021;1341:107-24. [PMID: 32072476 DOI: 10.1007/5584_2020_491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Mancuso M, Orsucci D, Logerfo A, Rocchi A, Petrozzi L, Nesti C, Galetta F, Santoro G, Murri L, Siciliano G. Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation. J Neurol 2010;257:774-81. [DOI: 10.1007/s00415-009-5409-7] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
29 Morris G, Anderson G, Dean O, Berk M, Galecki P, Martin-subero M, Maes M. The Glutathione System: A New Drug Target in Neuroimmune Disorders. Mol Neurobiol 2014;50:1059-84. [DOI: 10.1007/s12035-014-8705-x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 86] [Article Influence: 11.3] [Reference Citation Analysis]
30 Manoli I, Sysol JR, Li L, Houillier P, Garone C, Wang C, Zerfas PM, Cusmano-Ozog K, Young S, Trivedi NS, Cheng J, Sloan JL, Chandler RJ, Abu-Asab M, Tsokos M, Elkahloun AG, Rosen S, Enns GM, Berry GT, Hoffmann V, DiMauro S, Schnermann J, Venditti CP. Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemia. Proc Natl Acad Sci U S A 2013;110:13552-7. [PMID: 23898205 DOI: 10.1073/pnas.1302764110] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 7.1] [Reference Citation Analysis]
31 Guha S, Mathew ND, Konkwo C, Ostrovsky J, Kwon YJ, Polyak E, Seiler C, Bennett M, Xiao R, Zhang Z, Nakamaru-Ogiso E, Falk MJ. Combinatorial glucose, nicotinic acid and N-acetylcysteine therapy has synergistic effect in preclinical C. elegans and zebrafish models of mitochondrial complex I disease. Hum Mol Genet 2021;30:536-51. [PMID: 33640978 DOI: 10.1093/hmg/ddab059] [Reference Citation Analysis]
32 Enns GM, Cohen BH. Clinical Trials in Mitochondrial Disease: An Update on EPI-743 and RP103. Journal of Inborn Errors of Metabolism and Screening 2017;5:232640981773301. [DOI: 10.1177/2326409817733013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
33 Hakuna L, Doughan B, Escobedo JO, Strongin RM. A simple assay for glutathione in whole blood. Analyst 2015;140:3339-42. [PMID: 25913023 DOI: 10.1039/c5an00345h] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
34 Rotroff DM, Oki NO, Liang X, Yee SW, Stocker SL, Corum DG, Meisner M, Fiehn O, Motsinger-Reif AA, Giacomini KM, Kaddurah-Daouk R. Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans. Front Pharmacol 2016;7:135. [PMID: 27378919 DOI: 10.3389/fphar.2016.00135] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
35 Moore T, Le A, Niemi AK, Kwan T, Cusmano-Ozog K, Enns GM, Cowan TM. A new LC-MS/MS method for the clinical determination of reduced and oxidized glutathione from whole blood. J Chromatogr B Analyt Technol Biomed Life Sci 2013;929:51-5. [PMID: 23660247 DOI: 10.1016/j.jchromb.2013.04.004] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 8.4] [Reference Citation Analysis]
36 Hosseinimehr SJ, Mahmoudzadeh A, Rafiei A. Arginine increases genotoxicity induced by methyl methanesulfonate in human lymphocytes. Cytotechnology 2013;65:379-84. [PMID: 22907509 DOI: 10.1007/s10616-012-9490-x] [Reference Citation Analysis]
37 Rahman S, Mayr JA. Disorders of Oxidative Phosphorylation. In: Saudubray J, Baumgartner MR, Walter J, editors. Inborn Metabolic Diseases. Berlin: Springer Berlin Heidelberg; 2016. pp. 223-42. [DOI: 10.1007/978-3-662-49771-5_14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
38 Wilnai Y, Enns GM, Niemi AK, Higgins J, Vogel H. Abnormal hepatocellular mitochondria in methylmalonic acidemia. Ultrastruct Pathol 2014;38:309-14. [PMID: 24933007 DOI: 10.3109/01913123.2014.921657] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
39 Aquilano K, Baldelli S, Cardaci S, Rotilio G, Ciriolo MR. Nitric oxide is the primary mediator of cytotoxicity induced by GSH depletion in neuronal cells. J Cell Sci 2011;124:1043-54. [PMID: 21363890 DOI: 10.1242/jcs.077149] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
40 Dingley S, Chapman KA, Falk MJ. Fluorescence-activated cell sorting analysis of mitochondrial content, membrane potential, and matrix oxidant burden in human lymphoblastoid cell lines. Methods Mol Biol 2012;837:231-9. [PMID: 22215552 DOI: 10.1007/978-1-61779-504-6_16] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
41 Yin CX, Xiong KM, Huo FJ, Salamanca JC, Strongin RM. Fluorescent Probes with Multiple Binding Sites for the Discrimination of Cys, Hcy, and GSH. Angew Chem Int Ed Engl 2017;56:13188-98. [PMID: 28703457 DOI: 10.1002/anie.201704084] [Cited by in Crossref: 251] [Cited by in F6Publishing: 209] [Article Influence: 50.2] [Reference Citation Analysis]
42 El-Hattab AW, Zarante AM, Almannai M, Scaglia F. Therapies for mitochondrial diseases and current clinical trials. Mol Genet Metab 2017;122:1-9. [PMID: 28943110 DOI: 10.1016/j.ymgme.2017.09.009] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 16.4] [Reference Citation Analysis]
43 Niemi AK, Brown C, Moore T, Enns GM, Cowan TM. Evidence of redox imbalance in a patient with succinic semialdehyde dehydrogenase deficiency. Mol Genet Metab Rep 2014;1:129-32. [PMID: 27896081 DOI: 10.1016/j.ymgmr.2014.02.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
44 Pastore A, Martinelli D, Piemonte F, Tozzi G, Boenzi S, Di Giovamberardino G, Petrillo S, Bertini E, Dionisi-Vici C. Glutathione metabolism in cobalamin deficiency type C (cblC). J Inherit Metab Dis 2014;37:125-9. [PMID: 23568438 DOI: 10.1007/s10545-013-9605-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
45 Kim TJ, Kim HJ, Kang M, Cho JH, Kim YG, Lee SM, Byun JS, Kim DY. Ginsenoside F2 induces cellular toxicity to glioblastoma through the impairment of mitochondrial function. Phytomedicine 2021;83:153483. [PMID: 33578358 DOI: 10.1016/j.phymed.2021.153483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Nasca A, Scotton C, Zaharieva I, Neri M, Selvatici R, Magnusson OT, Gal A, Weaver D, Rossi R, Armaroli A, Pane M, Phadke R, Sarkozy A, Muntoni F, Hughes I, Cecconi A, Hajnóczky G, Donati A, Mercuri E, Zeviani M, Ferlini A, Ghezzi D. Recessive mutations in MSTO1 cause mitochondrial dynamics impairment, leading to myopathy and ataxia. Hum Mutat 2017;38:970-7. [PMID: 28544275 DOI: 10.1002/humu.23262] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
47 Yuan K, Cuntín-Abal C, Jurado-Sánchez B, Escarpa A. Smartphone-Based Janus Micromotors Strategy for Motion-Based Detection of Glutathione. Anal Chem 2021;93:16385-92. [PMID: 34806352 DOI: 10.1021/acs.analchem.1c02947] [Reference Citation Analysis]
48 Blankenberg FG, Kinsman SL, Cohen BH, Goris ML, Spicer KM, Perlman SL, Krane EJ, Kheifets V, Thoolen M, Miller G, Enns GM. Brain uptake of Tc99m-HMPAO correlates with clinical response to the novel redox modulating agent EPI-743 in patients with mitochondrial disease. Molecular Genetics and Metabolism 2012;107:690-9. [DOI: 10.1016/j.ymgme.2012.09.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
49 Jorge-finnigan A, Gámez A, Pérez B, Ugarte M, Richard E. Different altered pattern expression of genes related to apoptosis in isolated methylmalonic aciduria cblB type and combined with homocystinuria cblC type. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2010;1802:959-67. [DOI: 10.1016/j.bbadis.2010.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
50 Haas RH. Autism and mitochondrial disease. Dev Disabil Res Revs 2010;16:144-53. [DOI: 10.1002/ddrr.112] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
51 Hall PL, Marquardt G, McHugh DM, Currier RJ, Tang H, Stoway SD, Rinaldo P. Postanalytical tools improve performance of newborn screening by tandem mass spectrometry. Genet Med 2014;16:889-95. [PMID: 24875301 DOI: 10.1038/gim.2014.62] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 9.9] [Reference Citation Analysis]
52 Polyak E, Ostrovsky J, Peng M, Dingley SD, Tsukikawa M, Kwon YJ, McCormack SE, Bennett M, Xiao R, Seiler C, Zhang Z, Falk MJ. N-acetylcysteine and vitamin E rescue animal longevity and cellular oxidative stress in pre-clinical models of mitochondrial complex I disease. Mol Genet Metab 2018;123:449-62. [PMID: 29526616 DOI: 10.1016/j.ymgme.2018.02.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
53 Kageyama Y, Kasahara T, Morishita H, Mataga N, Deguchi Y, Tani M, Kuroda K, Hattori K, Yoshida S, Inoue K, Kato T. Search for plasma biomarkers in drug-free patients with bipolar disorder and schizophrenia using metabolome analysis: Metabolome on psychiatric disorders. Psychiatry Clin Neurosci 2017;71:115-23. [DOI: 10.1111/pcn.12461] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
54 Vasta V, Sedensky M, Morgan P, Hahn SH. Altered redox status of coenzyme Q9 reflects mitochondrial electron transport chain deficiencies in Caenorhabditis elegans. Mitochondrion 2011;11:136-8. [PMID: 20849980 DOI: 10.1016/j.mito.2010.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
55 Clarke C, Xiao R, Place E, Zhang Z, Sondheimer N, Bennett M, Yudkoff M, Falk MJ. Mitochondrial respiratory chain disease discrimination by retrospective cohort analysis of blood metabolites. Mol Genet Metab 2013;110:145-52. [PMID: 23920046 DOI: 10.1016/j.ymgme.2013.07.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
56 Koene S, Spaans E, Van Bortel L, Van Lancker G, Delafontaine B, Badilini F, Beyrath J, Smeitink J. KH176 under development for rare mitochondrial disease: a first in man randomized controlled clinical trial in healthy male volunteers. Orphanet J Rare Dis 2017;12:163. [PMID: 29037240 DOI: 10.1186/s13023-017-0715-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
57 Falk MJ, Sondheimer N. Mitochondrial genetic diseases. Curr Opin Pediatr 2010;22:711-6. [PMID: 21045694 DOI: 10.1097/MOP.0b013e3283402e21] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
58 Qiu P, Hou W, Wang H, Lei KKW, Wang S, Chen W, Pardeshi LA, Prothro K, Shukla Y, Su SSM, Schrump DS, Chen Q, Deng CX, Xu X, Wang R. Sirt1 deficiency upregulates glutathione metabolism to prevent hepatocellular carcinoma initiation in mice. Oncogene 2021;40:6023-33. [PMID: 34433910 DOI: 10.1038/s41388-021-01993-1] [Reference Citation Analysis]
59 Enns GM, Kinsman SL, Perlman SL, Spicer KM, Abdenur JE, Cohen BH, Amagata A, Barnes A, Kheifets V, Shrader WD, Thoolen M, Blankenberg F, Miller G. Initial experience in the treatment of inherited mitochondrial disease with EPI-743. Mol Genet Metab 2012;105:91-102. [PMID: 22115768 DOI: 10.1016/j.ymgme.2011.10.009] [Cited by in Crossref: 128] [Cited by in F6Publishing: 112] [Article Influence: 11.6] [Reference Citation Analysis]
60 El-hattab AW, Emrick LT, Chanprasert S, Craigen WJ, Scaglia F. Mitochondria: Role of citrulline and arginine supplementation in MELAS syndrome. The International Journal of Biochemistry & Cell Biology 2014;48:85-91. [DOI: 10.1016/j.biocel.2013.12.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
61 Mancuso M, Orsucci D, Filosto M, Simoncini C, Siciliano G. Drugs and mitochondrial diseases: 40 queries and answers. Expert Opinion on Pharmacotherapy 2012;13:527-43. [DOI: 10.1517/14656566.2012.657177] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
62 Enns GM. Treatment of mitochondrial disorders: antioxidants and beyond. J Child Neurol 2014;29:1235-40. [PMID: 24985754 DOI: 10.1177/0883073814538509] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
63 Suomalainen A. Biomarkers for mitochondrial respiratory chain disorders. J Inherit Metab Dis 2011;34:277-82. [PMID: 20941643 DOI: 10.1007/s10545-010-9222-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
64 Click RE. Obesity, longevity, quality of life: alteration by dietary 2-mercaptoethanol. Virulence 2010;1:509-15. [PMID: 21178502 DOI: 10.4161/viru.1.6.13803] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
65 Murayama K, Shimura M, Liu Z, Okazaki Y, Ohtake A. Recent topics: the diagnosis, molecular genesis, and treatment of mitochondrial diseases. J Hum Genet 2019;64:113-25. [PMID: 30459337 DOI: 10.1038/s10038-018-0528-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
66 Goldstein A, Vockley J. Clinical trials examining treatments for inborn errors of amino acid metabolism. Expert Opinion on Orphan Drugs 2016;5:153-64. [DOI: 10.1080/21678707.2017.1275565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Wajner M, Vargas CR, Amaral AU. Disruption of mitochondrial functions and oxidative stress contribute to neurologic dysfunction in organic acidurias. Arch Biochem Biophys 2020;696:108646. [PMID: 33098870 DOI: 10.1016/j.abb.2020.108646] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
68 Millichap LE, Damiani E, Tiano L, Hargreaves IP. Targetable Pathways for Alleviating Mitochondrial Dysfunction in Neurodegeneration of Metabolic and Non-Metabolic Diseases. Int J Mol Sci 2021;22:11444. [PMID: 34768878 DOI: 10.3390/ijms222111444] [Reference Citation Analysis]
69 Richard E, Gallego-Villar L, Rivera-Barahona A, Oyarzábal A, Pérez B, Rodríguez-Pombo P, Desviat LR. Altered Redox Homeostasis in Branched-Chain Amino Acid Disorders, Organic Acidurias, and Homocystinuria. Oxid Med Cell Longev 2018;2018:1246069. [PMID: 29743968 DOI: 10.1155/2018/1246069] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
70 Pastore A, Petrillo S, Tozzi G, Carrozzo R, Martinelli D, Dionisi-Vici C, Di Giovamberardino G, Ceravolo F, Klein MB, Miller G, Enns GM, Bertini E, Piemonte F. Glutathione: a redox signature in monitoring EPI-743 therapy in children with mitochondrial encephalomyopathies. Mol Genet Metab 2013;109:208-14. [PMID: 23583222 DOI: 10.1016/j.ymgme.2013.03.011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
71 Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R, Anselm I, Cohen BH, Falk MJ, Greene C, Gropman AL, Haas R, Hirano M, Morgan P, Sims K, Tarnopolsky M, Van Hove JL, Wolfe L, DiMauro S. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med 2015;17:689-701. [PMID: 25503498 DOI: 10.1038/gim.2014.177] [Cited by in Crossref: 226] [Cited by in F6Publishing: 169] [Article Influence: 28.3] [Reference Citation Analysis]
72 Li N, Oquendo E, Capaldi RA, Robinson JP, He YD, Hamadeh HK, Afshari CA, Lightfoot-Dunn R, Narayanan PK. A systematic assessment of mitochondrial function identified novel signatures for drug-induced mitochondrial disruption in cells. Toxicol Sci 2014;142:261-73. [PMID: 25163676 DOI: 10.1093/toxsci/kfu176] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
73 Shaham O, Slate NG, Goldberger O, Xu Q, Ramanathan A, Souza AL, Clish CB, Sims KB, Mootha VK. A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells. Proc Natl Acad Sci U S A 2010;107:1571-5. [PMID: 20080599 DOI: 10.1073/pnas.0906039107] [Cited by in Crossref: 94] [Cited by in F6Publishing: 94] [Article Influence: 7.8] [Reference Citation Analysis]
74 Hesam Shariati MB, Mirzaei F, Soleimani Asl S, Mosavi L, Sohrabi M. Acute and Chronic Effects of 3-4, Methylenedioxymethamphetamine on Pyramidal Cells of Hippocampus. Avicenna J Neuro Psych Physio 2014;1. [DOI: 10.17795/ajnpp-21812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
75 Dobrowolski SF, Phua YL, Sudano C, Spridik K, Zinn PO, Wang Y, Bharathi S, Vockley J, Goetzman E. Phenylalanine hydroxylase deficient phenylketonuria comparative metabolomics identifies energy pathway disruption and oxidative stress. Mol Genet Metab 2021:S1096-7192(21)00686-7. [PMID: 33846068 DOI: 10.1016/j.ymgme.2021.04.002] [Reference Citation Analysis]